Literature DB >> 4027622

Systemic and nigral application of amphetamine both cause an increase in extracellular concentration of ascorbate in the caudate nucleus of the rat.

R L Wilson, R M Wightman.   

Abstract

Unmodified microvoltammetric electrodes and electrochemically modified cylindrical electrodes, both constructed from carbon fibers, were used to determine changes in ascorbate concentration in the caudate nucleus of the anesthetized rat following administration of amphetamine. The increased ascorbate levels with systemic amphetamine originate from a CNS source, since the response is not eliminated in adrenalectomized animals, and does not occur when p-hydroxyamphetamine, an agent with peripheral actions similar to amphetamine, is used as a stimulus. Local application of amphetamine in the caudate nucleus results in an increase in catechols. However, this procedure results in a decrease of the extracellular concentration of ascorbate. Unilateral nigral infusion of dopamine or amphetamine leads to a significant increase in the concentrations of ascorbate detected bilaterally in the caudate nuclei with in vivo electrochemistry. In contrast, the paradigm causes a decrease in extracellular catechols on the ipsilateral side and an increase on the contralateral side. These experiments demonstrate that the extracellular level of ascorbate is not correlated with dopamine secretion. Furthermore, the data show that the action of amphetamine on ascorbate concentration in the caudate nucleus is in part mediated by the nigral actions of amphetamine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027622     DOI: 10.1016/0006-8993(85)90086-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

Review 1.  Corticostriatal network dysfunction in Huntington's disease: Deficits in neural processing, glutamate transport, and ascorbate release.

Authors:  George V Rebec
Journal:  CNS Neurosci Ther       Date:  2018-02-21       Impact factor: 5.243

2.  On the mechanism of d-amphetamine-induced changes in glutamate, ascorbic acid and uric acid release in the striatum of freely moving rats.

Authors:  M Miele; M A Mura; P Enrico; G Esposito; P A Serra; R Migheli; D Zangani; E Miele; M S Desole
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

3.  Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.

Authors:  E D Abercrombie; P DeBoer
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

4.  Behavioral activation in rats requires endogenous ascorbate release in striatum.

Authors:  G V Rebec; Z Wang
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

5.  Ascorbate antagonizes the behavioral effects of amphetamine by a central mechanism.

Authors:  L K White; M Carpenter; M Block; A Basse-Tomusk; T W Gardiner; G V Rebec
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Dysregulation of corticostriatal ascorbate release and glutamate uptake in transgenic models of Huntington's disease.

Authors:  George V Rebec
Journal:  Antioxid Redox Signal       Date:  2013-06-19       Impact factor: 8.401

Review 7.  Ferritinophagy and α-Synuclein: Pharmacological Targeting of Autophagy to Restore Iron Regulation in Parkinson's Disease.

Authors:  Matthew K Boag; Angus Roberts; Vladimir N Uversky; Linlin Ma; Des R Richardson; Dean L Pountney
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.